IP Library › Granted Patent US 11,390,614
Granted Patent B2
US 11,390,614 · App. 16/762,795 · Granted Jul 19, 2022

Method for preparing benzofuran derivative

Inventors: Weidong Lu (Shanghai, CN); Chao Xu (Shanghai, CN); Haoyu Zhang (Shanghai, CN); Qiyun Shao (Shanghai, CN); Jun Feng (Shanghai, CN); Feng He (Shanghai, CN)
Assignees: JIANGSU HENGRUI MEDICINE CO., LTD.; SHANGHAI HENGRUI PHARMACEUTICAL CO., LTD.
C07D405/14C07C51/363
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,390,614
App. No.
16/762,795
Granted
Jul 19, 2022
Kind
B2
Abstract

Disclosed is a method for preparing a benzofuran derivative. In particular, provided is a method for preparing a benzofuran derivative, wherein according to the method provided, reaction steps required to synthesize the benzofuran substance in the prior art can be effectively shortened.

Claims (16)

1. A method for preparing a benzofuran derivative represented by formula IV, wherein a compound represented by formula IV is prepared by reacting of a compound represented by formula VI with a compound represented by formula V,

wherein X and Y are each independently selected from fluorine, chlorine, bromine, iodine, —OS(O) 2 alkyl and —OS(O) 2 aryl, preferably iodine and bromine;

R 1 , R 2 , R 3 are each identical or different, and are each independently selected from the group consisting of hydrogen atom, halogen, alkyl, haloalkyl, alkoxy, haloalkoxy, amino, nitro, hydroxyl, cyano, cycloalkyl, heterocyclyl, aryl, heteroaryl, —OR 4 , —C(O)R 4 , —C(O)OR 4 , —OS(O) 2 alkyl, and —OS(O) 2 aryl, —S(O) m R 4 , —S(O) m NR 5 R 6 and —(CH 2 )xR a , wherein alkyl, haloalkyl, heterocyclyl, aryl and heteroaryl are each independently and optionally substituted by one or more substituents selected from the group consisting of alkyl, haloalkyl, halogen, amino, nitro, cyano, hydroxyl, alkoxy, haloalkoxy, hydroxyalkyl, cycloalkyl, heterocyclyl, aryl and heteroaryl;

E is selected from the group consisting of hydrogen atom, halogen, alkyl, haloalkyl, alkoxy, haloalkoxy, nitro, cyano, cycloalkyl, heterocyclyl, aryl, heteroaryl, —OR 4 , —C(O)R 4 , —C(O)OR 4 , —OS(O) 2 alkyl, and —OS(O) 2 aryl, —S(O) m R 4 , —S(O) m NR 5 R 6 and —(CH 2 )xR a , wherein the alkyl, haloalkyl, heterocyclyl, aryl and heteroaryl are each independently and optionally substituted by any one or more substituents selected from the group consisting of alkyl, haloalkyl, halogen, amino, nitro, cyano, hydroxyl, alkoxy, haloalkoxy, hydroxyalkyl, cycloalkyl, heterocyclyl, aryl and heteroaryl;

R a is selected from the group consisting of halogen, cycloalkyl, heterocyclyl and —NR 5 R 6 , wherein the cycloalkyl and heterocyclyl are independently and optionally substituted by one or more substituents selected from the group consisting of alkyl, haloalkyl, halogen, amino, nitro, cyano, hydroxyl, alkoxy, haloalkoxy, hydroxyalkyl, cycloalkyl, heterocyclyl, aryl and heteroaryl;

R 4 is selected from the group consisting of hydrogen atom, alkyl, haloalkyl, alkoxy, hydroxyalkyl, hydroxyl, amino, cycloalkyl, heterocyclyl, aryl and heteroaryl;

R 5 and R 6 are each identical or different, and are each independently selected from the group consisting of hydrogen atom, alkyl, alkoxy, hydroxyalkyl, hydroxyl, amino, carboxylate, cycloalkyl, heterocyclyl, aryl and heteroaryl, wherein the alkyl, amino, cycloalkyl, heterocyclyl, aryl and heteroaryl are each independently and optionally substituted by one or more substituents selected from the group consisting of alkyl, halogen, hydroxyl, amino, carboxylate, nitro, cyano, alkoxy, hydroxyalkyl, cycloalkyl, heterocyclyl, aryl and heteroaryl;

M is selected from carboxyl, hydrogen and silicyl, preferably hydrogen;

m is 0, 1 or 2;

x is 0, 1, 2 or 3.

2. The method according to claim 1 , wherein the reacting of the compound represented by formula VI with the compound represented by formula V is performed under the action of at least one metal catalyst and/or at least one alkaline substance, wherein the metal catalyst is selected from a metal palladium catalyst, a metal zinc catalyst, a metal copper catalyst and a metal nickel catalyst, preferably a metal copper catalyst, and more preferably a monovalent metal copper catalyst, wherein the alkaline substance is selected from the group consisting of KHCO 3 , NaHCO 3 , Na 2 CO 3 , Ba(OH) 2 , K 3 PO 4 , Cs 2 CO 3 , K 2 CO 3 , KF, CsF, KCN, NaCN, NaOH, KOH, Et 3 N, DIPEA, DABCO, NaOMe, NaOEt, t BuOK, t BuONa, NaH, DBU, TMG, LHMDS, NaHMDS, n-BuLi, sodium tert-pentoxide, diethylamine and dicyclohexylamine, preferably t BuOK and t BuONa.

3. The method according to claim 2 , wherein the reaction solvent is one or more selected from the group consisting of dimethylformamide, 1-methyl-2-pyrrolidone, tetrahydrofuran, methyltetrahydrofuran, dioxane, toluene, xylene, dimethylsulfoxide, diethyl ether, isopropyl ether, methyl tert-butyl ether, acetonitrile, propionitrile, isopropanol, propanol, ethanol, methanol and water.

4. The method according to claim 2 , wherein the reaction is carried out under the protection of an inert gas selected from nitrogen, argon and helium, preferably argon.

5. The method according to claim 1 which comprises the step of a compound represented by formula IVa is prepared by reacting of a compound represented by formula VIa with a compound represented by formula Va,

6. The method for preparing the compound represented by formula IVa according to claim 5 , which further comprises preparing the compound represented by formula VIa by using a compound represented by formula VIIa under the action of a brominating reagent and at least one acid,

wherein the brominating reagent is selected from the group consisting of HBr, Br 2 , NBS, DBDMH, HOBr, AcOBr, CF 3 COOBr, NH 4 Br, TBBDA, PBBS and tribromoisocyanurate, preferably NBS or DBDMH, wherein the acid is selected from the group consisting of AlCl 3 , SbCl 5 , FeCl 3 , FeBr 3 , SnCl 4 , TiCl 4 , ZnCl 2 , BF 3 , acetic acid, sulfuric acid, hydrochloric acid and trifluoroacetic acid, preferably sulfuric acid or trifluoroacetic acid.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 8, 2020
From: LU, WEIDONG; XU, CHAO; ZHANG, HAOYU; SHAO, QIYUN; FENG, JUN; HE, FENG
To: JIANGSU HENGRUI MEDICINE CO., LTD.; SHANGHAI HENGRUI PHARMACEUTICAL CO., LTD
Reel/Frame 052616/0859 →
Priority Claims (1)
CN 201711104888.3 · Nov 10, 2017 · national
Continuity (1)
Related Publication 20210188822A1 · Jun 24, 2021
Cited By (1)
US 51,039